» Articles » PMID: 35214102

Moxifloxacin Liposomes: Effect of Liposome Preparation Method on Physicochemical Properties and Antimicrobial Activity Against

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2022 Feb 26
PMID 35214102
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was the development of optimal sustained-release moxifloxacin (MOX)-loaded liposomes as intraocular therapeutics of endophthalmitis. Two methods were compared for the preparation of MOX liposomes; the dehydration-rehydration (DRV) method and the active loading method (AL). Numerous lipid-membrane compositions were studied to determine the potential effect on MOX loading and retention in liposomes. MOX and phospholipid contents were measured by HPLC and a colorimetric assay for phospholipids, respectively. Vesicle size distribution and surface charge were measured by DLS, and morphology was evaluated by cryo-TEM. The AL method conferred liposomes with higher MOX encapsulation compared to the DRV method for all the lipid compositions used. Cryo-TEM showed that both liposome types had round vesicular structure and size around 100-150 nm, while a granular texture was evident in the entrapped aqueous compartments of most AL liposomes, but substantially less in DRV liposomes; X-ray diffraction analysis demonstrated slight crystallinity in AL liposomes, especially the ones with highest MOX encapsulation. AL liposomes retained MOX for significantly longer time periods compared to DRVs. Lipid composition did not affect MOX release from DRV liposomes but significantly altered drug loading/release in AL liposomes. Interestingly, AL liposomes demonstrated substantially higher antimicrobial potential towards growth and biofilm susceptibility compared to corresponding DRV liposomes, indicating the importance of MOX retention in liposomes on their activity. In conclusion, the liposome preparation method/type determines the rate of MOX release from liposomes and modulates their antimicrobial potential, a finding that deserves further in vitro and in vivo exploitation.

Citing Articles

An Injectable Hydrogel Bioimplant Loaded with Engineered Exosomes and Triple Anti-Tuberculosis Drugs with Potential for Treating Bone and Joint Tuberculosis.

Huang J, Li H, Mei Y, Yi P, Ren Y, Wang Y Int J Nanomedicine. 2025; 20:1285-1302.

PMID: 39911262 PMC: 11794387. DOI: 10.2147/IJN.S480288.


Potential of Liposomal FTY720 for Bone Regeneration: Proliferative, Osteoinductive, Chemoattractive, and Angiogenic Properties Compared to Free Bioactive Lipid.

Mouzoura P, Marazioti A, Gkartziou F, Metsiou D, Antimisiaris S Int J Nanomedicine. 2025; 20():239-265.

PMID: 39802384 PMC: 11724662. DOI: 10.2147/IJN.S494512.


Nanoliposomal system for augmented antibacterial and antiproliferative efficacy of L. extract.

Nizam N, Taner G, Cagal M Toxicol Res (Camb). 2024; 13(6):tfae198.

PMID: 39677494 PMC: 11645532. DOI: 10.1093/toxres/tfae198.


Nanomedicines as a cutting-edge solution to combat antimicrobial resistance.

Solanki R, Makwana N, Kumar R, Joshi M, Patel A, Bhatia D RSC Adv. 2024; 14(45):33568-33586.

PMID: 39439838 PMC: 11495475. DOI: 10.1039/d4ra06117a.


Daptomycin Liposomes Exhibit Enhanced Activity against Staphylococci Biofilms Compared to Free Drug.

Gkartziou F, Plota M, Kypraiou C, Gauttam I, Kolonitsiou F, Klepetsanis P Pharmaceutics. 2024; 16(4).

PMID: 38675120 PMC: 11054717. DOI: 10.3390/pharmaceutics16040459.


References
1.
Schilt Y, Berman T, Wei X, Nativ-Roth E, Barenholz Y, Raviv U . Effect of the ammonium salt anion on the structure of doxorubicin complex and PEGylated liposomal doxorubicin nanodrugs. Biochim Biophys Acta Gen Subj. 2021; 1865(5):129849. DOI: 10.1016/j.bbagen.2021.129849. View

2.
Arbisser L . Safety of intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery. J Cataract Refract Surg. 2008; 34(7):1114-20. DOI: 10.1016/j.jcrs.2008.03.017. View

3.
Hoogkamp-Korstanje J, Roelofs-Willemse J . Comparative in vitro activity of moxifloxacin against Gram-positive clinical isolates. J Antimicrob Chemother. 2000; 45(1):31-9. DOI: 10.1093/jac/45.1.31. View

4.
Wang R, Gao Y, Liu A, Zhai G . A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances. J Drug Target. 2021; 29(7):687-702. DOI: 10.1080/1061186X.2021.1878366. View

5.
Sanderson N, Guo B, Jacob A, Handley P, Cunniffe J, Jones M . The interaction of cationic liposomes with the skin-associated bacterium Staphylococcus epidermidis: effects of ionic strength and temperature. Biochim Biophys Acta. 1996; 1283(2):207-14. DOI: 10.1016/0005-2736(96)00099-5. View